Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassan Zaraket

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Journal of Virology|August 23, 2013
Fecal influenza in mammals: selection of novel variantsZeynep A Koçer, John Obenauer, Hassan Zaraket, et al.
Journal of Clinical Microbiology|December 19, 2008
In vivo and in vitro alterations in influenza A/H3N2 virus M2 and hemagglutinin genes: effect of passage in MDCK-SIAT1 cells and conventional MDCK cellsDanjuan Li, Reiko Saito, Yasushi Suzuki, et al.
Japanese Journal of Infectious Diseases|November 28, 2012
Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from children in a community with low antimicrobial pressure in JapanTaketo Otsuka, Hassan Zaraket, Koyata Fujii, et al.
Vaccines|November 11, 2020
Influenza Vaccination Hesitancy among Healthcare Workers in South Al Batinah Governorate in Oman: A Cross-Sectional StudySalah T Al Awaidy, Zayid K Al Mayahi, Malak Kaddoura, et al.
Frontiers in Pharmacology|August 28, 2020
COVID-19 Therapeutic Options Under InvestigationMalak Kaddoura, Malak AlIbrahim, Ghina Hijazi, et al.
Vaccines|December 30, 2020
Platforms Exploited for SARS-CoV-2 Vaccine DevelopmentShilu Mathew, Muhammed Faheem, Neeraja A Hassain, et al.
European Journal of Pharmacology|September 13, 2020
Macrophage responses associated with COVID-19: A pharmacological perspectiveGeorge W Booz, Raffaele Altara, Ali H Eid, et al.
Journal of Clinical Microbiology|June 26, 2009
Emerging genotypes of human respiratory syncytial virus subgroup A among patients in JapanYugo Shobugawa, Reiko Saito, Yasuko Sano, et al.
Antiviral Therapy|June 3, 2010
Genomic events contributing to the high prevalence of amantadine-resistant influenza A/H3N2Hassan Zaraket, Reiko Saito, Yasushi Suzuki, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 8, 2024
A cost-effectiveness analysis of reduced viral transmission with baloxavir marboxil versus oseltamivir or no treatment for seasonal and pandemic influenza management in the United KingdomSvenn Alexander Kommandantvold, Annabelle Lemenuel-Diot, Chris Skedgel, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Journal of Virology|August 23, 2013
Fecal influenza in mammals: selection of novel variantsZeynep A Koçer, John Obenauer, Hassan Zaraket, et al.
Journal of Clinical Microbiology|December 19, 2008
In vivo and in vitro alterations in influenza A/H3N2 virus M2 and hemagglutinin genes: effect of passage in MDCK-SIAT1 cells and conventional MDCK cellsDanjuan Li, Reiko Saito, Yasushi Suzuki, et al.
Japanese Journal of Infectious Diseases|November 28, 2012
Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from children in a community with low antimicrobial pressure in JapanTaketo Otsuka, Hassan Zaraket, Koyata Fujii, et al.
Vaccines|November 11, 2020
Influenza Vaccination Hesitancy among Healthcare Workers in South Al Batinah Governorate in Oman: A Cross-Sectional StudySalah T Al Awaidy, Zayid K Al Mayahi, Malak Kaddoura, et al.
Frontiers in Pharmacology|August 28, 2020
COVID-19 Therapeutic Options Under InvestigationMalak Kaddoura, Malak AlIbrahim, Ghina Hijazi, et al.
Vaccines|December 30, 2020
Platforms Exploited for SARS-CoV-2 Vaccine DevelopmentShilu Mathew, Muhammed Faheem, Neeraja A Hassain, et al.
European Journal of Pharmacology|September 13, 2020
Macrophage responses associated with COVID-19: A pharmacological perspectiveGeorge W Booz, Raffaele Altara, Ali H Eid, et al.
Journal of Clinical Microbiology|June 26, 2009
Emerging genotypes of human respiratory syncytial virus subgroup A among patients in JapanYugo Shobugawa, Reiko Saito, Yasuko Sano, et al.
Antiviral Therapy|June 3, 2010
Genomic events contributing to the high prevalence of amantadine-resistant influenza A/H3N2Hassan Zaraket, Reiko Saito, Yasushi Suzuki, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 8, 2024
A cost-effectiveness analysis of reduced viral transmission with baloxavir marboxil versus oseltamivir or no treatment for seasonal and pandemic influenza management in the United KingdomSvenn Alexander Kommandantvold, Annabelle Lemenuel-Diot, Chris Skedgel, et al.
Pageof 10